Literature DB >> 8434143

Capsular hyaluronic acid in Pasteurella multocida type A and its counterpart in type D.

K K Pandit1, J E Smith.   

Abstract

Hyaluronic acid was demonstrated in the capsule extract of 39/39 Pasteurella multocida type A strains by sodium chloride gradient chromatography followed by Alcian blue staining, and by a turbidometric method using acidified horse serum. Treatment with hyaluronidase from various sources eliminated these reactions. An Alcian blue staining substance of closely similar chromatographic properties occurred in capsule extracts of 14/16 type D strains but it resisted hyaluronidase and was thought to be an acidic polysaccharide differing from the hyaluronic acid of type A. Turbidometric values were lower than with type A strains, but were unaltered by hyaluronidase treatment. The type D substance could be precipitated from capsule extract by acriflavin. Both type A and D strains were mucoid and displayed large capsule zones in stained preparations. Photomicrographic measurements showed that hyaluronidase treatment of cell suspensions markedly reduced capsule dimensions of type A but not type D strains. When type A strains were cross streaked against a hyaluronidase + Staphylococcus aureus, their growth became non-mucoid at the intersection: mucoid type D strains were unaffected. Neither hyaluronic acid nor the hyaluronidase resistant type D substance could be detected in type B or E strains.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8434143     DOI: 10.1016/0034-5288(93)90005-z

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  7 in total

1.  Identification of a distinct, cryptic heparosan synthase from Pasteurella multocida types A, D, and F.

Authors:  Paul L Deangelis; Carissa L White
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

2.  Role of capsule in the pathogenesis of fowl cholera caused by Pasteurella multocida serogroup A.

Authors:  J Y Chung; I Wilkie; J D Boyce; K M Townsend; A J Frost; M Ghoddusi; B Adler
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

3.  Synthesis of heparosan oligosaccharides by Pasteurella multocida PmHS2 single-action transferases.

Authors:  Anaïs A E Chavaroche; Lambertus A M van den Broek; Carmen Boeriu; Gerrit Eggink
Journal:  Appl Microbiol Biotechnol       Date:  2011-12-24       Impact factor: 4.813

4.  In vitro synthesis of heparosan using recombinant Pasteurella multocida heparosan synthase PmHS2.

Authors:  Anaïs A E Chavaroche; Jan Springer; Floor Kooy; Carmen Boeriu; Gerrit Eggink
Journal:  Appl Microbiol Biotechnol       Date:  2009-09-16       Impact factor: 4.813

5.  Virulence Determinants and Antimicrobial Profiles of Pasteurella multocida Isolated from Cattle and Humans in Egypt.

Authors:  Mohamed Sabry Abd Elraheam Elsayed; Samah Mahmoud Eldsouky; Tamer Roshdy; Lamia Said; Nahed Thabet; Tamer Allam; A B Abeer Mohammed; Ghada M Nasr; Mohamed S M Basiouny; Behiry A Akl; Maha M Nader; Al Shaimaa Hasan; Ahmed Salah
Journal:  Antibiotics (Basel)       Date:  2021-04-22

6.  Inhibition of Pasteurella multocida Adhesion to Rabbit Respiratory Epithelium Using Lectins.

Authors:  Magda Patricia Carrillo; Nhora María Martinez; María Del Pilar Patiño; Carlos Arturo Iregui
Journal:  Vet Med Int       Date:  2015-02-24

7.  Eliminating the capsule-like layer to promote glucose uptake for hyaluronan production by engineered Corynebacterium glutamicum.

Authors:  Yang Wang; Litao Hu; Hao Huang; Hao Wang; Tianmeng Zhang; Jian Chen; Guocheng Du; Zhen Kang
Journal:  Nat Commun       Date:  2020-06-19       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.